Applied Immune Technologies

company

About

Applied Immune Technologies is focused on developing therapeutic molecules for cancer, viral, and autoimmune diseases. 

  • 101 - 250

Details

Industries
Biotechnology,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2006
Number Of Employee
101 - 250
Operating Status
Active

Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.